The association of choroidal thickness with rheumatoid factor and anti-cyclic citrullinated peptide in rheumatoid arthritis

被引：0
|
作者：
Arif Ülkü Yener
Kubilay Şahin
机构：
[1] Keçiören Training and Research Hospital,Department of Ophthalmology
[2] Keçiören Training and Research Hospital,Department of Rheumatology
来源：
International Ophthalmology | 2020年 / 40卷
关键词：
Rheumatoid arthritis; Choroidal thickness; Optical coherence tomography angiography; Rheumatoid factor; Anti-cyclic citrullinated peptide antibody;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：935 / 941
页数：6
相关论文
共 50 条
  • [41] Diagnostic performance of anti-cyclic citrullinated antibodies and IgM rheumatoid factor in rheumatoid arthritis
    Lemos, Ana
    Ramos, Maria Piedade
    Furtado, Maria Jose
    Carvalho, Carla
    Santos, Maria Jose
    da Silva, J. Canas
    Ventura, Humberto
    ACTA REUMATOLOGICA PORTUGUESA, 2007, 32 (04): : 345 - 349
  • [42] Clinical Significance of Combined Anti-Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor Assays in Rheumatoid Arthritis Diagnosis
    Cao, Qingmei
    Wang, Yanfeng
    Jing, Yuanyuan
    ARCHIVES OF RHEUMATOLOGY, 2015, 30 (02): : 104 - 108
  • [43] DOES THE PRESENCE OF RHEUMATOID FACTOR AND/ OR ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVITY AFFECT THE MANIFESTATIONS OF RHEUMATOID ARTHRITIS?
    Chan, A.
    Gao, X.
    See, W.
    Leong, K.
    Koh, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 988 - 989
  • [44] Intermetatarsal bursitis is frequent in patients with established rheumatoid arthritis and is associated with anti-cyclic citrullinated peptide and rheumatoid factor
    Hammer, Hilde Berner
    Kvien, Tore K.
    Terslev, L.
    RMD OPEN, 2019, 5 (02):
  • [45] Impact of treatment with infliximab on anti-cyclic citrullinated peptide antibody and rheumatoid factor in patients with rheumatoid arthritis.
    Mubashir, E
    Ahmed, MM
    Wolf, RE
    Hayat, S
    Hall, VC
    Shi, R
    Berney, SM
    ARTHRITIS AND RHEUMATISM, 2005, 52 (12): : 4098 - 4098
  • [46] Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis
    Vallbracht, I
    Rieber, J
    Oppermann, M
    Förger, F
    Siebert, U
    Helmke, K
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (09) : 1079 - 1084
  • [47] Meta-analysis: Diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis
    Nishimura, Kunihiro
    Sugiyama, Daisuke
    Kogata, Yoshinori
    Tsuji, Goh
    Nakazawa, Takashi
    Kawano, Seiji
    Saigo, Katsuyasu
    Morinobu, Akio
    Koshiba, Masahiro
    Kuntz, Karen M.
    Kamae, Isao
    Kumagai, Shunichi
    ANNALS OF INTERNAL MEDICINE, 2007, 146 (11) : 797 - 808
  • [48] Comparison of anti-mutated citrullinated vimentin with anti-cyclic citrullinated peptide and rheumatoid factors for the diagnosis of rheumatoid arthritis
    Song, J. S.
    Park, G. B.
    Park, A. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 369 - 369
  • [49] Anti-cyclic citrullinated peptide and rheumatoid factor in HIV positive patients
    Zeljko Romic
    Lovorka Derek
    Vitomir Burek
    Adriana Unic
    Tihana Serdar
    Domagoj Marijancevic
    Jadranka Morovic-Vergles
    Josko Mitrovic
    Mladen Petrovecki
    Rheumatology International, 2011, 31 : 1607 - 1610
  • [50] Evaluation of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Omani Patients with Rheumatoid Arthritis
    Al-Shukaili, Ahmed
    Al-Ghafri, Saif
    Al-Marhoobi, Safia
    Alkaabi, Juma
    INTERNATIONAL JOURNAL OF RHEUMATOLOGY, 2012, 2012
12345